Not the most auspicious start to a friendship of
families, and it showed that while I might have been very highly trained in
medicine and managed to gain the prize in medicine for my cohort at King’s, but
common things were common in general practice and I had had so little
experience in common things that clearly I had a long way to go. I had never
seen a case of measles; I vowed never to miss another. We recovered slowly, but
I always felt I had rather a lot to prove.
I was on safer ground with depression, and was
curious about how many cases I might find in my day-to-day work. In retrospect,
what was different about the cases I saw was that the primary reason for coming
to see me was to improve matters. I can only barely remember writing
certificates for time off from work. There were the usual background reasons to
mild depression – the loss of a relationship in the late teens or early
twenties, a loss through death of a loved one (including loss of child in an
early pregnancy), and occasionally an episode of bullying at work, or a public
shaming for some misdemeanour. There were certainly a range of ‘interesting’
people in our community, but I cannot remember seeing many cases that I would
be prepared to call a personality disorder (with or without depression). I did
know of a couple of people who had spent some weeks in St Augustine’s, our
local psychiatric hospital near Canterbury, but oddly they were through social
contacts rather than patients of the practice.
Another oddity was that very few of the over 3000
patients in my practice had been medicated for a mental illness, and it was
only very rarely that any of my colleagues took the option of discussing a
patient with a mental health problem. So was this something to do with the type
of community – semi-rural and seasonal holiday oriented? Was it to do with the
slower pace of the times, or perhaps fewer personal life expectations, or
perhaps to do with the sense of community support that existed? Or perhaps it
was due to almost full employment for those that sought it, even if some of it
was seasonal. Or was it perhaps related to stigma; that is you stoically
managed your own mental health, and would have been very embarrassed to admit
that there was a ‘mental problem’.
I was, as you may imagine, on the lookout with a
slightly higher alertness. Strangely, the patients who did come to see me came
for physical symptoms. There were several people who complained of tiredness,
sluggish thinking, weight gain and mild depression, who clearly had early
myxoedema and, after relevant tests and a visit to a local physician, responded
very well to treatment with Thyroxine.
Conversely there were several people who
complained of a racing heart or dizziness, or excessive perspiration. After we
excluded and/or treated a thyroid problem, there were a few left who had clear
cut generalised anxiety, came from an anxious family, and responded to fairly
simple explanations, some desensitization procedures I had learned, or a very
short course of diazepam to help them through a time of change.
There were a small group of people, more men than
women, who complained of tiredness and poor functioning at work accompanied by
occasional dizziness, or recurrent and sometimes very severe headaches. Many
used the word ‘depressed’, but a physical examination revealed a very high
blood pressure. This, once treated with an antihypertensive seemed to sort
matters out. Occasionally I managed to get them to lose a small amount of weight,
and increase their exercise load through walks along the sea wall. And this,
too, seemed to contain the problem. The modern penchant for competing marathons
had not been invented. Nobody seemed to need the gymnasium-based frenzy of
various forms of exercise that we now see touted, and the one or two gyms in
Thanet seemed to be limited to boxers.
With those where there was no other cause for
their depression, I was perfectly comfortable to prescribe either of two
tricyclic antidepressants, and take them through the course and see them
improve.
There was one spectacular case. I was asked to do
a house call on a young woman who had recently given birth to a healthy son.
The midwife and family members were anxious that she seemed in despair, seemed
to be losing her interest in her new baby, and spent all her time in bed
sleeping or weeping. Her husband complained that she had become totally
different and he was ‘unable to reach her’. Her mother had moved into the house
to ensure the physical care of her daughter, and her new grandson. But she was
beginning to feel worn out.
My clinical history suggested a severe postnatal
depression, and I thought she should be in a safe hospital environment. This
suggestion was rejected with anger and threats of self-harm, and my patient
(and her mother) begged me to treat her at home. I was anxious. Clearly she
needed to have a rapid response to treatment, and I wondered how we would be
able to manage. At home I did some reading, and then took the step of phoning
one of my senior colleagues at King’s who had been involved in the trial of intravenous
clomipramine when I was a registrar. He remained enthusiastic, quoted his
recent apparently excellent research results about the speed of recovery, but
did acknowledge that he had not heard of clomipramine use in postnatal
depression. He encouraged me to ‘give it a go’.
I spoke to the local chemist, and he found out
from the pharmaceutical company he could gain access to a 10-day course of
clomipramine in liquid form for intravenous use as part of a slow infusion of a
daily saline drip. I completed a further physical of my patient, which included
an ECG using our new portable machine. I explained the whole process carefully
to my patient and the family, including any possible side effects. Excited and
nervous they agreed.
And so we began. We organised to stick the saline
drips to the doorframe using a clothes hanger. Each morning I would go round to
the house after morning surgery, and the district nurse and I would set up the
drip with the clomipramine, and slowly infuse the whole mixture over about an
hour. During that time I sat next to the bed and, after the first couple of
days of awkward silence, we began to talk. Part of that was to check any
perceived reaction to our infusion, adverse or otherwise. Part was about the
birth, her baby, her family history, her hopes for the future. We checked her
pulse at regular intervals, but not once in the ten days did we get anything
like an adverse reaction.
About day 7, both the family and the district
nurse began to report radical change. Sleep and appetite had improved, her
demeanour was happier, her interest in and attention to her baby was far more
positive, and other family members seemed relieved and happy. She had been up
much more during the day focused on the needs of the baby and her daily chores.
After day 10 I switched her to a small maintenance dose. Her cardiac status and
her ECG showed no observable difference to the first time.
None of the family called me in over the next few
weeks, but I popped in to see her and the baby briefly once a week, and then we
saw her at the surgery from then on. Her two weekly, and then monthly, visits
were always brief and filled with the happy development of her baby.
I was never to need to use clomipramine again, and
it was only some years later that I was by chance to read a research report of
several deaths from cardiac malfunction during the early intravenous treatment phase
of treatment. I shuddered (as I do now recalling the episode) at what risks I
had taken in my youthful enthusiasm.
No comments:
Post a Comment